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Abstract 
Objective: The aim of this study was to examine the decision-making (DM) styles 
of younger (18-39 years), middle-aged (40-59 years), and older (≥60 years) can-
cer survivors, the type and role of social support, and patient satisfaction with 
cancer treatment DM. 
Method: Adult cancer survivors (N = 604) were surveyed using Qualtrics on-
line software. 
Results: Older adults reported significantly lower influence of support on DM 
than younger adults. The most common DM style for the age groups was col-
laborative DM with their doctors. Younger age was a significant predictor of in-
dependent (p < .05), collaborative with family (p < .001), delegated to doctor 
(p < .01), delegated to family (p < .001), and demanding (p < .001) DM styles. 
Discussion: Despite having lower received social support in cancer treatment 
DM, older adults were more satisfied with their DM than younger and middle-
aged adults. Health care workers should be aware of different DM styles and in-
fluence of social networks to help facilitate optimal patient DM and satisfaction. 
Keywords:  decision making, older adults, age differences, social support 
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Introduction 
The number of people diagnosed with cancer during their lifetime has been 
steadily increasing. Currently, one in three women and one in two men in the 
United States will develop cancer in their lifetime (American Cancer Society, 
2015). Increases in the number of individuals diagnosed with cancer each year, 
due in large part to aging and growth of the population, as well as improving 
survival rates, have led to an ever-increasing number of older cancer survivors 
(Siegel, Ma, Zou, & Jemal, 2014; Smith, Smith, Hurria, Hortobagyi, & Buchholz, 
2009). Despite this increase, older survivors are understudied relative to pediat-
ric survivors. Furthermore, in comparison with their younger counterparts, older 
adults with cancer experience several inadequacies in their cancer treatment and 
care, such as receiving less aggressive treatments (Bastiaannet et al., 2010; Sch-
onberg et al., 2014; Schonberg et al., 2010). 
Despite known differences in treatment, few studies have examined how older, 
middle-aged, and younger adults with cancer choose their treatment (Elkin, Kim, 
Casper, Kissane, & Schrag, 2007; Lifford et al., 2015; Pinquart & Duberstein, 
2004), and how the decision-making (DM) process differs by age (Puts et al., 2015; 
Shelton et al., 2013). Often, patient DM is not the result of purely rational eval-
uation of all relevant information but is influenced by situational, interpersonal, 
and individual determinants in addition to prognosis (Petrisek, Laliberte, Allen, 
& Mor, 1997; Puts et al., 2015; Shelton et al., 2013). In geriatric oncology, bal-
ancing risks and benefits is generally difficult due to the lack of data on survival 
and quality of life (Repetto, Comandini, & Mammoliti, 2001; Tariman, Berry, Co-
chrane, Doorenbos, & Schepp, 2012). In addition, older adults with cancer may 
present age-related issues such as multiple comorbidities, cognitive issues, and 
polypharmacy, which can further complicate treatment DM (Puts, Papoutsis, 
Springall, & Tourangeau, 2012). 
Cancer patients frequently consult with spouses, adult children, and extended 
family members when making medical treatment decisions (Chouliara, Kearney, 
Stott, Molassiotis, & Miller, 2004; Schumacher et al., 2008). Due to the multi-
dimensional nature of treatment DM among older adults with cancer, the influ-
ence of social network members (family, friends, significant others, and physi-
cians) and types of supportive behaviors (emotional, instrumental, informational, 
and appraisal) must be considered. Furthermore, the size and support provided 
by social networks may differ by age according to the socioemotional selectivity 
theory, which posits that as individuals age, they reduce their social networks 
to invest in emotionally meaningful goals and activities (Carstensen, Isaacow-
itz, & Charles, 1999).  
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Several theoretical frameworks have attempted to explain the role of social 
support on treatment DM. The most applicable was developed by Degner and Be-
aton (1987) who identified four patterns of DM, which include doctor-controlled 
(i.e., passive), patient-controlled (i.e., active), jointly controlled (i.e., shared), and 
family-controlled. However, this model does not take into account the extent to 
which patients desire decisional support and the extent to which they perceive 
receiving decisional support. A recent typology, the Family DECIDE (Determi-
nants of Clinical Decision-Making) Typology developed by Krieger (2014), fo-
cuses on cancer treatment DM and the interactions between patients and family 
members in five distinct styles. This configuration (Figure 1), moving clockwise 
from bottom left, includes independent (no desired and received DM support), 
isolated (desired DM support, no received DM support), collaborative (desired 
and received DM support), delegated (strong desire for DM support, received DM 
support), and demanding (no desired DM support, received DM support) family 
DM styles. Results from this typology stress the importance of understanding 
the patient preference for autonomy or interdependence in his or her DM and the 
received DM support from his or her family (Krieger, Krok-Schoen, et al., 2015; 
Krieger, Palmer-Wackerly, et al., 2015). 
Numerous studies have explored age differences in the cancer treatment DM 
process; however, the results are inconsistent (Presutti et al., 2014). For example, 
the few studies that have examined older adult DM preferences found older adults 
Figure 1. Typology of family decision-making styles.
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have a preference for a passive role in treatment DM compared with younger 
adults (Cassileth, Zupkis, Sutton-Smith, & March, 1980; Davison & Breckon, 
2012; Levinson, Kao, Kuby, & Thisted, 2005; Xie, Wang, Feldman, & Zhou, 2014). 
Conversely, other studies have found no age differences in cancer treatment DM 
preferences (Brown et al., 2012; Bruera, Willey, Palmer, & Rosales, 2002; Ram-
felt, Langius, & Bjoervell, 2000) while others have found the large majority of 
older adult patients preferred some or full control in treatment DM (Tariman, 
Doorenbos, Schepp, Singhal, & Berry, 2014). Thus, it is unclear regarding what 
role older cancer survivors play in their treatment DM, how much influence their 
social network has on their treatment decisions, and how their treatment DM 
compare with younger and middle-aged cancer survivors. This study aims to (a) 
describe the DM styles of younger, middle-aged, and older cancer survivors; and 
(b) explore the role of social support on their cancer treatment DM. 
Method 
We developed a cross-sectional survey about cancer treatment DM, clinical trial 
enrollment, and information seeking behaviors among cancer survivors. Anon-
ymous surveys were administered in April 2014 using Qualtrics survey software 
(Qualtrics Laboratories, Inc., Provo, UT, USA). Eligible participants were recruited 
from the Qualtrics web panel via an email invitation with an embedded, secure 
individualized link to the survey instrument. 
To be eligible for this study, potential participants had to be 18 years or older, 
U.S. residents, had received a cancer diagnosis within the past 2 years, and cur-
rent participants in Qualtrics survey network. Informed consent was obtained 
through an online informed consent form that provided study information, the 
survey duration, participant rights, and contact information for a study repre-
sentative about questions or concerns. The university institutional review board 
approved this study. 
Measures 
Demographic characteristics. Participants provided information about their age, 
gender, race, ethnicity, marital status, education, household income (in US dol-
lars), employment status, and health insurance. Age was divided into three age 
groups: younger (18-39 years), middle-aged (40-59 years), and older (<60 years). 
The cutoff of 60 years of older age was based on cutoffs used in previous studies 
of cancer patients (Krok, Baker, & McMillan, 2013; Pinquart, Frohlich, & Silbere-
isen, 2007; Politi, Enright, & Weihs, 2007). 
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Prognosis and perceptions of cancer. Respondents were first asked about their can-
cer including date of diagnosis, type of diagnosed cancer, and chances that can-
cer is/will be cured (less than 50% or more than 50%). Next, participants were 
asked to respond to the statements, “Having cancer is/was a severe threat to my 
health,” “Having cancer is/was a serious threat to my quality of life,” and “Having 
cancer is/was very harmful to my well-being.” Responses were on a 5-point Lik-
ert-type scale (1 = strongly disagree to 5 = strongly agree). Responses were divided 
into agree (i.e., strongly agree, agree) and disagree (i.e., strongly disagree, disagree). 
Participants were also asked, “What are the chances that your cancer is/ will 
be cured?” Responses were on a 5-point scale (90% or better, about 75%, about 
50/50, about 25%, 10% or less). Responses for prognosis of cancer were dichoto-
mized into ≥50% chance that the cancer is/will be cured (“90% or better, about 
75%, about 50/50”) and <50% chance that the cancer is/will be cured (“about 
25%, 10% or less”). 
DM style. As modeled by Krieger (2014), treatment DM style was categorized 
into five patterns: independent, isolated, collaborative, delegated, and demand-
ing. This scale measures the respondent’s level of control in treatment DM, us-
ing six statements to indicate different response categories that best describe 
the extent to which the respondents were involved in treatment DM. Based on 
their responses, participants were categorized as independent/isolated (“I made 
the important decisions about my cancer treatment by myself”), collaborative 
(“I made the important decisions about my cancer treatment with my doctor”; “I 
made the important decisions about my cancer treatment with my family mem-
bers”), delegated (“My doctor made all of the important decisions about my can-
cer treatment”; “My family made all of the important decisions about my cancer 
treatment”), or demanding (“I went along with my families’ advice on the impor-
tant decisions, even when I disagreed”) roles. Responses were on a 5-point Lik-
ert-type scale (1 = strongly disagree to 5 = strongly agree). 
Satisfaction. To measure satisfaction in treatment DM, participants were asked to 
respond to two statements: “The treatment decision I made was the best decision 
for me personally” and “Satisfaction with your role in cancer treatment decision-
making process.” Responses were on a 5-point Likert-type scale (1 = strongly dis-
agree to 5 = strongly agree). 
Type of social support and influence. As developed by House (1981), social support 
type was categorized into four categories: emotional (feelings of trust and love), 
informational (providing someone with information or advice), instrumental 
(providing resources such time or money), and appraisal (providing evaluative 
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feedback). To assess type of social support received during treatment DM, par-
ticipants were asked to respond in separate reference to their oncologist, signifi-
cant other, and adult children to the statements, “Showing care and concern for 
me” (emotional support), “Giving me valuable information about my treatment 
options” (informational support), “Giving me advice about which treatment op-
tion would be better for me” (instrumental support), and “Giving me a different 
point of view (appraisal support).” Responses were on a 5-point Likert-type scale 
(1 = strongly disagree to 5 = strongly agree). 
Influence of social support members was measured by the question, “How 
much did the opinion of the following individuals—family doctor, oncologist, 
significant other, adult child(ren), parent(s), sibling(s), friend(s)—influence 
your decisions about your cancer treatment?” Responses were on a 5-point Lik-
ert-type scale (1 = we did not discuss, 2 = not at all, 3 = a little, 4 = moderately, 
and 5 = very much). 
Analyses 
Participant characteristics were compared descriptively using means for con-
tinuous variables and percentages for categorical variables. One-way ANOVAs 
and Tukey’s HSD post hoc comparisons were used to determine significant age 
differences in continuous demographic data. Cross-tabulations with chi-square 
comparisons were used to determine significant age differences in categorical 
demographic data and the participants’ prognosis and perceptions of cancer (con-
trolling for cancer type and gender). 
Univariate general linear models, controlling for cancer type and gender, were 
used to determine possible age differences in the DM styles, influence of social sup-
port on DM, and types of support received by social support members. Forward 
stepwise linear regression models were used to determine the significant predictors 
for each DM style. Covariates entered in the final model included age, gender, race, 
education, marital status, income, and health insurance (Step 1), and time since 
diagnosis, cancer type, and survival prognosis (Step 2). Perceived cancer threat to 
health, well-being, and quality of life were excluded due to multicollinearity. Sep-
arate analyses were conducted for the entire sample and by age group. All analy-
ses were conducted using IBM SPSS Statistics 23.0 (IBM Corp, Armonk, NY, USA). 
Results 
Sample and Cancer Characteristics 
Baseline characteristics of the 606 participants are shown in Table 1. For 
the younger participants, the mean age was 30.8 years, and the majority of 
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Table 1. Sample Characteristics.
 Younger  Middle-aged Older 
 18-39 years  40-59 years 60+ years 
 (n = 227) (n = 183)  (n = 196)
Variable n (%) n (%) n (%)  p
Age, M (SD)  30.8 (5.06)  49.6 (5.75)  68.6 (6.4)
Gender (% female)  142 (62.6)  131 (71.6)  110 (56.1)  .01
Race
   White  162 (71.4)  160 (87.4)  190 (96.9)  <.001
   Black  30 (13.2)  13 (7.1)  4 (2.1)
   Asian  26 (11.5)  7 (3.8)  0 (0.0)
   Other  9 (4.0)  3 (1.6)  2 (1.0)
Marital status
   Married  157 (69.2)  120 (65.6)  130 (66.3)  <.001
   Divorced/ 3 (1.3)  40 (21.8)  52 (26.6)
      separated/
      widowed
   Single  67 (29.5)  23 (12.6)  14 (7.1)
Education
   Less than high 5 (2.2)  1 (0.6)  2 (1.0)  <.001
      school
   High school/GED  22 (9.7)  35 (19.1)  28 (14.3)
   Some college  64 (28.2)  78 (42.6)  85 (43.4)
   College graduate/ 136 (59.9)  69 (37.7)  81 (41.3)
      graduate school
Income
   Less than $30,000  27 (11.9)  42 (23.0)  46 (23.6)  .20
   $30,001- $75,000  110 (48.5)  83 (45.3)  98 (50.2)
   $75,001 or more  90 (39.6)  90 (31.7)  51 (26.2)
Health insurance
   Private  175 (78.8)  115 (66.1)  64 (32.7)  <.001
   Public  35 (15.8)  54 (31.0)  115 (64.3)
   Uninsured  12 (5.4)  5 (2.9)  0 (0.0)
Type of cancer
   Breast  84 (37.0)  55 (30.1)  32 (16.3)  <.001
   Prostate  29 (12.8)  16 (8.7)  26 (13.3)
   Lung  31 (13.7)  12 (6.6)  12 (6.1)
   Colorectal  12 (5.3)  12 (6.6)  12 (6.1)
Diagnosis date
   <3 months ago  44 (15.4)  20 (10.9)  21 (10.7)  <.001
   3-6 months ago  73 (32.2)  30 (16.4)  21 (10.7)
   7-12 months ago  75 (33.0)  55 (30.1)  45 (23.0)
   13-24 months ago  35 (15.4)  78 (42.6)  109 (55.6)
(continued)
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participants (62.6%) were female, White (71.4%), married or living as a cou-
ple (69.2%), had at least a high school education (97.8%), private health insur-
ance (78.8%), and household incomes <$75,000/year (60.4%). The most common 
type of cancer among younger participants was breast (37.0%), followed by lung 
(13.7%) and prostate cancer (12.8%) 
Middle-aged participants were predominately female (71.6%) with a mean age 
of 49.6 years. The majority of the middle-aged participants were White (87.4%), 
married or living as a couple (65.6%), had at least a high school education (99.4%), 
private health insurance (66.1%), and household incomes <$75,000/year (68.3%). 
The most common type of cancer among middle-aged participants was breast 
(30.1%), followed by prostate (8.7%) and lung cancer (6.6%). 
Older participants were predominately female (56.1%) with a mean age of 
68.6 years. The majority of the older participants were White (96.9%), married 
or living as a couple (66.3%), had at least a high school education (99%), public 
health insurance (64.3%), and household incomes <$75,000/year (73.8%). The 
most common type of cancer among older participants was breast (16.3%), fol-
lowed by prostate (13.3%) and lung cancer (6.1%). 
Table 1. (continued)
 Younger  Middle-aged Older 
 18-39 years  40-59 years 60+ years 
 (n = 227) (n = 183)  (n = 196)
Variable n (%) n (%) n (%)  p
Prognosis and perceptions of cancera
   Having cancer is/ 212 (97.2)  155 (88.6)  127 (74.7)  <.001
      was a severe
      threat to my health
   Having cancer is/   209 (96.3)  147 (86.5)  121 (70.3)  <.001
      was a serious
      threat to my
      quality of life  
   Having cancer is/   213 (96.8)  150 (90.4)  126 (75.4)  <.001
      was very harmful
      to my well-being
   More than 50%   199 (90.5)  157 (90.8)  160 (93.0)  .64
      chance that your
      cancer is/will be cured
Some variables have missing data. GED = General Educational Development.
a. Adjusted for cancer type and gender.
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Significant differences were found in race, marital status, education, and in-
surance between the three age groups. Controlling for gender and cancer type, 
there were significant age differences in perceived threat of cancer to their 
health (97.2% vs. 88.6% vs. 74.7%, p < .001), quality of life (96.3% vs. 86.5% 
vs. 70.3%, p < .001), and well-being (96.8% vs. 90.4% vs. 75.4%, p < .001) for 
younger, middle-aged, and older adults, respectively, with younger adults re-
porting the highest perceived threat of cancer. There were no significant age 
differences regarding the participants’ curative prognosis for the younger, mid-
dle-aged, and older adults (90.5% vs. 90.8% vs. 93.0%, p = .64, respectively; Ta-
ble 1). 
Social Support 
For all age groups, the highest received support was emotional support from 
their significant other followed by informational support from their oncologist. 
However, significant differences were found in the amount of emotional, instru-
mental, informational, and appraisal support reported among the age groups, 
with the oldest group reporting the lowest received social support in their can-
cer treatment DM. After controlling for covariates, there was a significant age 
group effect on oncologist appraisal support, F(2, 426) = 9.91, p < .001. There 
were also significant age group effects on emotional, F(2, 316) = 4.05, p < .05; 
instrumental, F(2, 316) = 11.40, p < .001; informational, F(2, 316) = 14.99, p < 
.001; and appraisal, F(2, 316) = 28.16, p < .001, support from significant oth-
ers. Finally, there were significant age group effects on emotional, F(2, 189) 
= 3.66, p < .05; instrumental, F(2, 189) = 11.96, p < .001; informational, F(2, 
189) = 13.44, p < .001; and appraisal, F(2, 189) = 20.92, p < .001, support from 
adult children (Table 2). 
Social Support Influence 
For all age groups, the highest reported social support influence on cancer treat-
ment DM was from their oncologist followed by their significant other. The 
amount of influence of social support on cancer treatment decisions also dif-
fered by age group, with the oldest group reporting the lowest levels of social 
support influence on their cancer treatment DM with the exception of the on-
cologist, in which the oldest age group was more influenced than the younger 
and middle-aged group. After controlling for covariates, there were significant 
age group effects on the influence of their family doctor, F(2, 411) = 21.49, p 
< .001; significant other, F(2, 342) = 5.54, p < .01; adult child(ren), F(2, 251) 
= 3.79, p < .05; parent(s), F(2, 303) = 52.32, p < .001; sibling(s), F(2, 347) = 
32.40, p < .001; and friend(s), F(2, 393) = 35.13, p < .001, on cancer treatment 
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DM (Table 3).   
DM Style and Satisfaction 
Due to multiple styles of DM employed simultaneously by the cancer survivors, 
the mean scores of agreement to the statements regarding DM styles are re-
ported. The highest reported DM style for the age groups was collaborative DM 
with doctors, followed by independent DM. 
However, the utilization of other different cancer treatment DM styles differed 
by age group. After controlling for covariates, there were significant age group 
effects on the utilization of independent, F(2, 429) = 3.47, p < .05; collaborative 
with family, F(2, 429) = 10.89, p < .001; delegated to doctor, F(2, 429) = 4.44, p 
Table 2. Social Support in Treatment Decisions by Age Group.
 Younger  Middle-aged Older 
 18-39 years  40-59 years 60+ years 
Variable n (%) n (%) n (%)  pa
Oncologistb
   Showing care and concern for me  4.23 (0.06)  4.19 (0.08)  4.12 (0.09)  .62
   Giving me valuable information  4.43 (0.06)  4.41 (0.07)  4.31 (0.08)  .46
      about my treatment options
   Giving me advice about which 4.40 (0.06)  4.31 (0.08)  4.17 (0.09)  .09
      treatment option would be
      better for me
   Giving me a different point of view  4.02 (0.07)  3.89 (0.09)  3.47 (0.10)  <.001
Significant otherc
   Showing care and concern for me  4.69 (0.05)  4.64 (0.06)  4.44 (0.07)  <.05
   Giving me valuable information  4.06 (0.09)  3.56 (0.12)  3.34 (0.14)  <.001
      about my treatment options
   Giving me advice about which 4.17 (0.08)  3.79 (0.10)  3.39 (0.12)  <.001
      treatment option would 
      be better for me
   Giving me a different point of view  4.42 (0.08)  3.97 (0.10)  3.42 (0.11)  <.001
Adult childrend
   Showing care and concern for me  4.46 (0.14)  4.31 (0.13)  3.99 (0.11)  <.05
   Giving me valuable information  3.79 (0.17)  3.09 (0.15)  2.72 (0.14)  <.001
      about my treatment options
   Giving me advice about which 3.69 (0.16)  3.01 (0.15)  2.61 (0.13)  <.001
      treatment option would be 
      better for me
   Giving me a different point of view  4.20 (0.16)  3.33 (0.14)  2.89 (0.13)  <.001
Scale: 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree.
a. Adjusted for cancer type and gender.
b. N = 602, n = 226 for younger adults, n = 183 for middle-aged adults, n = 193 for older adults.
c. N = 443, n = 173 for younger adults, n = 136 for middle-aged adults, n = 134 for older adults.
d. N = 287, n = 52 for younger adults, n = 84 for middle-aged adults, n = 151 for older adults.
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< .05; delegated to family, F(2, 429) = 25.10, p < .001; and demanding, F(2, 429) 
= 27.72, p < .001, DM (Table 4).  
There were high satisfaction scores for all age groups. Older adults reported 
higher satisfaction with their role in the treatment DM process (M = 4.40, SD 
= 1.04) than the younger (M = 4.06, SD = 1.03) and middle-aged (M = 4.25, 
SD = 1.04) groups. After controlling for covariates, there were significant age 
group effects on the satisfaction with their role in the treatment DM process, 
Table 3. Social Support Influence on Cancer Treatment Decisions by Age Group.
 Younger  Middle-aged Older 
 18-39 years  40-59 years 60+ years 
Variable M (SD) M (SD) M (SD)  pa
The opinion of my family doctor  4.14 (0.10)  3.81 (0.12)  3.07 (0.13)  <.001
The opinion of my oncologist  4.61 (0.06)  4.59 (0.07)  4.67 (0.09)  .72
The opinion of my significant other  4.43 (0.08)  4.19 (0.10)  3.99 (0.12)  <.01
The opinion of my adult child(ren)  3.53 (0.14)  3.21 (0.15)  2.95 (0.15)  <.05
The opinion of parent(s)  4.04 (0.08)  3.42 (0.12)  1.96 (0.19)  <.001
The opinion of my sibling(s)  3.72 (0.09)  3.24 (0.12)  2.33 (0.15)  <.001
The opinion of my friend(s)  3.59 (0.08)  3.03 (0.11)  2.35 (0.12)  <.001
Scale: 1 = we did not discuss, 2 = not at all, 3 = a little, 4 = moderately, 5 = very much.
a. Adjusted for cancer type and gender.
Table 4. Patient Decision-Making Style by Age Group.
 Younger  Middle-aged Older 
 18-39 years  40-59 years 60+ years 
 (n = 226) (n = 183)  (n = 196)
Variable M (SD) M (SD) M (SD)  pa
Decision-making style
Independent  3.88 (0.08)  3.64 (0.10)  3.55 (0.11)  <.05
Collaborative
   Doctor  4.35 (0.06)  4.26 (0.08)  4.45 (0.08)  .22
   Family  3.75 (0.09)  3.53 (0.11)  3.08 (0.12)  <.001
Delegated
   Doctor  3.35 (0.09)  2.96 (0.11)  3.12 (0.12)  <.05
   Family  2.86 (0.08)  2.41 (0.10)  1.92 (0.11)  <.001
Demanding (family-controlled)  2.74 (0.08)  2.50 (0.10)  1.71 (0.11)  <.001 
Scale: 1 = strongly disagree, 2 = disagree, 3 = neither agree nor disagree, 4 = agree, 5 = strongly agree.
a. Adjusted for cancer type and gender.
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F(2, 429) = 4.17, p < .05. Older adults also reported higher endorsement of the 
statement, “The treatment decision I made was the best decision for me per-
sonally” (M = 4.56, SD = 0.79) than younger (M = 4.32, SD = 0.77) and middle-
aged (M = 4.44, SD = 0.77) groups. After controlling for covariates, there were 
significant age group effects on the satisfaction with their treatment decision, 
F(2, 429) = 3.38, p < .05. 
Predictors of DM Styles 
Independent DM. There were no significant demographic (age, gender, race, ed-
ucation, marital status, income, health insurance) or cancer-related (diagnosis 
date, cancer threat, and survival prognosis) predictors for independent DM style. 
Collaborative DM. Analyses found that income was the only significant predictor 
of reporting collaborative DM with their doctor, F(10, 596) = 0.90, p = .54. Spe-
cifically, participants who had higher incomes (β = .06, p < .05) were significantly 
more likely to report collaborative DM with their doctor. Analyses found that 
age, gender, race, and marital status were significant predictors of reporting col-
laborative DM with their family, F(10, 597) = 5.76, p < .001. Specifically, partic-
ipants were significantly more likely to report collaborative DM with their fam-
ily if they were younger (β = −.29, p < .001), female (β = .34, p < .01), non-White 
(β = .15, p < .05), and married (β = −.12, p < .001). 
Delegated and demanding DM. Analyses found that age, education, time since di-
agnosis, and cancer type were significant predictors of reporting delegated DM 
to their doctor, F(10, 597) = 3.45, p < .001. Specifically, participants who were 
younger (β = −.23, p < .01), had lower education (β = −.11, p < .05), were recently 
diagnosed with cancer (β = −.18, p < .01), and had breast cancer (β = .09, p < .01) 
were significantly more likely to report delegated DM to their doctor. 
Age, gender, marital status, and time since diagnosis were significant predic-
tors of reporting delegated DM to their family, F(10, 597) = 7.17, p < .001. Specif-
ically, participants were significantly more likely to report delegated DM to their 
family if they were younger (β = −.47, p < .001), male (β = −.23, p < .05), married 
(β = −.09, p < .01), and were recently diagnosed with cancer (β = −.14, p < .05). 
Age and gender were significant predictors of reporting demanding DM, F(10, 
596) = 6.81, p < .001. Specifically, participants were significantly more likely to 
report demanding DM if they were younger (β = −.46, p < .001) and male (β = 
−.39, p < .001) (Table 5).  
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Discussion 
This study examined the treatment DM styles of older, middle-aged, and younger 
cancer survivors, and the role of social support on their cancer treatment DM. In 
this study, collaborative DM with doctors and independent DM was the most en-
dorsed DM style for all age groups. However, there were differences in treatment 
DM styles among the age groups, with younger age being a significant predictor 
of collaborative DM with doctor, delegated DM to doctor, delegated DM to family, 
and demanding DM from family. The finding of younger adults preferring more 
family involvement than older cancer survivors is somewhat surprising. This re-
sult contrasts previous studies that have found older adults were more likely to 
prefer passive DM roles than younger adults (Cassileth et al., 1980; Davison & 
Breckon, 2012; Levinson et al., 2005; Xie et al., 2014). One can suggest that the 
paternalistic model of physician–patient relationship (Rosenstein, 1986) is los-
ing ground and that patients of all ages are becoming more active participants 
in their health care. This shift may be attributed to the growth of the shared DM 
approach (Elwyn et al., 2012), where clinicians and patients share the best avail-
able evidence when faced with the task of making decisions, and where patients 
are supported to consider options, to achieve informed preferences (Elwyn et 
al., 2010; Elwyn et al., 2012). Future studies should continue to evaluate the pa-
tient–physician DM processes while considering the influence of the patient’s so-
cial support network. 
Older participants reported less received social support and less influence 
from their social network on their cancer treatment DM. Previous studies have 
found that family and significant others influence cancer treatment DM (Arora, 
Finney Rutten, Gusafson, Moser, & Hawkins, 2007; Petrisek et al., 1997; Schon-
berg et al., 2014; Sio et al., 2014). In contrast with our study, Sio and colleagues 
(2014) found that the amount of influence from social networks on treatment 
DM does not differ by age. Our study’s finding of age differences in the influence 
of social network members may be explained by older adults’ extensive previ-
ous and varied life experiences with the comorbidities and multiple exposures 
to the health care system (Tariman et al., 2014). Previous studies have found 
that older adults’ DM has been noted to be more “experiential,” that is, more 
likely than younger adults to integrate new information with prior experiences, 
rendering older adults less reliant on others for information and subsequently 
less influenced regarding their opinions on cancer DM (Gould, 1999; Locken-
hoff & Carstensen, 2004). In addition, this finding is supported by previous 
studies that have found older adults’ support systems have little influence on 
their treatment decisions (Ciambrone, 2006). It also provides evidence for the 
Socioemotional Selectivity theory, which assumes with age, individuals reduce 
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their social networks to provide meaningful social interactions (Carstensen et 
al., 1999). This preference for limited, close social networks is further high-
lighted among older individuals with a cancer diagnosis (Pinquart & Silberei-
sen, 2006). Thus, these results suggest that the presence and influence of so-
cial networks of cancer patient populations differ by age. 
A number of studies have shown age-associated differences in adjustment to 
cancer diagnosis, with younger adults having worse quality of life and well-be-
ing, more disease concerns, and depression (Avis, Crawford, & Manuel, 2004; 
Krok et al., 2013; Linden, Vodermaier, MacKenzie, & Greig, 2012). Younger 
adults also may consider a cancer diagnosis as an “off-time event” and more of 
a crisis compared with older adults, who may perceive their cancer diagnosis 
as an “on-time” event, normal and expected (Neugarten, 1996). Furthermore, 
the DM approach may differ in that younger adults believe they have a longer 
life expectancy and want to ensure they are making the treatment decision that 
will offer them the best chance of survival. They also may rely more on the sup-
port of their family because of possible child care and career obligations com-
pared with older adults. It is important for future studies to explore the models 
of DM within families, the DM preference of patients, and family members’ as-
sumed or assigned roles in this DM process to improve patient communication 
and satisfaction with DM (Krieger, Krok-Schoen, et al., 2015; Krieger, Palmer-
Wackerly, et al., 2015). 
Strengths/Limitations 
Our study has several important strengths including the large sample of cancer 
survivors, the examination of multiple DM styles, and possible correlates of these 
styles. It also sheds light on the received support and influence of social network 
members on treatment DM. In addition to the cross-sectional nature of the study 
design, there were some additional limitations. 
First, the data are based on self-report and we do not know the specific details 
about the participants’ cancer treatments and prognosis. Second, participants 
were asked about their perspective of treatment DM and support received; fu-
ture studies would benefit from including the perspectives of patients’ social net-
works as well as patients’ desired support, which would have better illustrated 
the DM process. Most participants were White, married, and well-educated, lim-
iting generalizability to different survivor populations and the general popula-
tion. Finally, this study did not include any external factors (e.g., other diseases, 
personal/social issues) that may affect cancer treatment DM.  
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Conclusion 
In summary, despite having lower received social support in cancer treatment 
DM, older adults are more satisfied with their treatment decisions than younger 
and middle-aged adults. Results found that collaborative DM with doctors was 
the most common DM style among cancer survivors. Finally, younger age was a 
significant predictor of collaborative DM with family, delegated DM to doctor, 
delegated DM to family, and demanding (family-controlled) DM, which demon-
strates the need for clinicians to inform and counsel patients and their families 
about different treatment options. Ideally, cancer treatment decisions would con-
sider all patients’ life expectancy, preferences, and social support networks to 
properly promote collaborative DM. 
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